Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPH-KNEE-OA
NCT07868770Not yet recruiting
- Sponsor
- Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in knee osteoarthritis (OA) (2 arms), sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index Total Score at Week 12 and Visual Analog Scale Pain Score at Week 12. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07868770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07868770.